Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Edus H Warren

14PUBLICATIONS

60CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursSocial determinants of healthImmunogenetics (incl. genetic immunology)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jun 17, 2025

Pralatrexate is effective in cytotoxic cutaneous T-cell lymphomas.

Christina Poh, Jenna M Voutsinas, Mazyar Shadman

|Apr 04, 2025

Phase I Study of Subcutaneous Rituximab Hyaluronidase Combined With CHOP Chemotherapy for the Treatment of Diffuse Large B-Cell Lymphoma in Uganda.

Manoj P Menon, Henry Ddungu, Kelvin R Mubiru

|Nov 18, 2024

Clinical Relevance of Intensive Laboratory Monitoring With Standard Venetoclax Ramp-Up for Chronic Lymphocytic Leukemia: A Real-World Experience.

Ivan J Huang, Grace T Baek, Jonathan Cohen

|May 30, 2024

Geographic EBV variants confound disease-specific variant interpretation and predict variable immune therapy responses.

Edward L Briercheck, Shashidhar Ravishankar, Elshafa Hassan Ahmed

|Feb 19, 2024

T-cells specific for KSHV and HIV migrate to Kaposi sarcoma tumors and persist over time.

Shashidhar Ravishankar, Andrea M H Towlerton, Iyabode L Tiamiyu

|Sep 02, 2023

Immunophenotypic correlates of sustained MRD negativity in patients with multiple myeloma.

David G Coffey, Francesco Maura, Edgar Gonzalez-Kozlova

Pageof 3

Frequent Collaborators

5 joint publications

Ryan C Lynch

5 joint publications

Mazyar Shadman

5 joint publications

Stephen D Smith

3 joint publications

David G Coffey

2 joint publications

Katharine A Lombardo

2 joint publications

Christopher S Carlson

2 joint publications

Jackson Orem

2 joint publications

Corey Casper

2 joint publications

Yuexin Xu

2 joint publications

Ajay K Gopal

Frequent Collaborators

5 joint publications

Ryan C Lynch

5 joint publications

Mazyar Shadman

5 joint publications

Stephen D Smith

3 joint publications

David G Coffey

Top Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on : Feb 10, 2023

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on : Mar 05, 2018

See more related videos

Top Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on : Feb 10, 2023

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on : Mar 05, 2018

See more related videos